← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
University Of Alabama At Birmi
$0
Total funding
8
Grants
Funding mix
By agency
NIH$0 · 8
By mechanism
N01$0 · 8
Investigators at University Of Alabama At Birmi
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
CLEAR-264002247$0
N01 · FY2004 · AR
CONSORTIUM FOR THE LONGITUDINAL EVALUATION OF AFRICAN-AMERICANS WITH E-268082278$0
N01 · FY2006 · AR
CLINICAL STUDIES OF THERAPIES FOR VIRUS INFECTIONS-266965306$0
N01 · FY2003 · AI
CLEAR-264002247$0
N01 · FY2003 · AR
NO.78 PHASE IIB CLINICAL TRIAL OF A TOPICAL AGENT TO PREVENT NON-MELAN-261015136$0
N01 · FY2003 · CA
PROSTATE, LUNG, COLO-RECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL -261975022$0
N01 · FY2003 · CA
RISK BIOMARKER EVALUATION FOR PROSTATE CANCER CHEMOPREVENTION TRIALS: -261985181$0
N01 · FY2003 · CA
A PHASE II CLINICAL TRIAL OF CELECOXIB (OR NSAID) IN SUBJECTS WITH ACT-261985183$0
N01 · FY2003 · CA
CLEAR-264002247$0
N01 · FY2002 · AR
NO.78 PHASE IIB CLINICAL TRIAL OF A TOPICAL AGENT TO PREVENT NON-MELAN-261015136$0
N01 · FY2002 · CA
PROSTATE, LUNG, COLO-RECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL -261975022$0
N01 · FY2002 · CA
RISK BIOMARKER EVALUATION FOR PROSTATE CANCER CHEMOPREVENTION TRIALS: -261985181$0
N01 · FY2002 · CA
A PHASE II CLINICAL TRIAL OF CELECOXIB (OR NSAID) IN SUBJECTS WITH ACT-261985183$0
N01 · FY2002 · CA
INTERVENTION TO IMPROVE ASTHMA MANAGEMENT/PREVENTION-268956077$0
N01 · FY2002 · HR
A PHASE II CLINICAL TRIAL OF CELECOXIB (OR NSAID) IN SUBJECTS WITH ACT-261085183$0
N01 · FY2006 · CA